Avid’s Holistic Approach and Core Philosophies Support Scale-Up Success 

Efficient scale-up of biopharmaceutical manufacturing processes can be complex and impacted by unforeseen challenges, so it is essential to partner with a CDMO that can support the full biologics development lifecycle — through extensive experience, a culture of collaboration, and facilities and equipment designed to facilitate seamless transfers. . 

In a new article, Avid Bioservices’ Pramthesh (Prem) Patel, Ph.D. (Vice President of Process Development and MS&T) examines the factors both impacting and predicting scaling needs as the therapeutic landscape shifts.